Wierzbicki, Anthony S.

The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association

Gidding, S. S., Ann Champagne, M., de Ferranti, S. D., Defesche, J., Ito, M. K., Knowles, J. W., McCrindle, B., Raal, F., Rader, D., Santos, R. D., et al. (2015) · Circulation

Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk Factors

Cited by 723

Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance

Rabar, S., Harker, M., O'Flynn, N., Wierzbicki, A. S., & On behalf of the Guideline Development Group (2014) · BMJ

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 292

Identification of PEX7 as the second gene involved in Refsum disease

van den Brink, D. M., Brites, P., Haasjes, J., Wierzbicki, A. S., Mitchell, J., Lambert-Hamill, M., de Belleroche, J., Jansen, G. A., Waterham, H. R., & Ronald Wanders, J. A. (2003) · The American Journal of Human Genetics

Metabolism and Genetic DisordersHereditary Neurological Disorders

Cited by 171

The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

Mikhailidis, D. P., & Wierzbicki, A. S. (2002) · Current Medical Research and Opinion

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 124

Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study

Meek, C., Wierzbicki, A. S., Jewkes, C., Twomey, P. J., Crook, M. A., Jones, A., & Viljoen, A. (2012) · Current Medical Research and Opinion

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 52

Adult Refsum disease: A form of tapetoretinal dystrophy accessible to therapy.

Rüether, K., Baldwin, E., Casteels, M., Feher, M. D., Horn, M., Kuranoff, S., Leroy, B. P., Wanders, R. J., & Wierzbicki, A. S. (2010) · Survey of Ophthalmology

Metabolism and Genetic DisordersRetinal Development and Disorders

Cited by 42

Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS)

Jones, A., Peers, K., Wierzbicki, A. S., Ramachandran, R., Mansfield, M., Dawson, C., Ochoa-Ferraro, A., Soran, H., Jenkinson, F., McDowell, I., et al. (2023) · Atherosclerosis

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 39

Options for the diagnosis of high blood pressure in primary care: a systematic review and economic model

Constanti, M., Boffa, R., Floyd, C. N., Wierzbicki, A. S., McManus, R. J., & Glover, M. (2021) · Journal of Human Hypertension

Blood Pressure and Hypertension StudiesHealth Systems, Economic Evaluations, Quality of Life

Cited by 21

Lipid clinic experience with bempedoic acid in three UK centres

Jakubowska, A., Al Hasani, W., Williams, J., MacMahon, Z., Balbas, B., Crook, M. A., Viljoen, A., Reynolds, T. M., & Wierzbicki, A. S. (2024) · Current Medical Research and Opinion

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 5